LXRX
Lexicon Pharmaceuticals Inc
Price:  
2.54 
USD
Volume:  
6,539,393.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX Relative Valuation

-581.8%
Upside

As of 2024-02-26, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (12.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.54 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -581.8%.

The range of the Relative Valuation is (8.56) - (13.93) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.2x - 23.8x 19.6x
Forward P/E multiples 13.2x - 21.5x 18.2x
Fair Price (8.56) - (13.93) (12.24)
Upside -437.1% - -648.4% -581.8%
2.54 USD
Stock Price
(12.24) USD
Fair Price

LXRX Relative Valuation - Historical P/E Data

Date P/E
2024-02-23 -3.93
2024-02-22 -3.66
2024-02-21 -3.88
2024-02-20 -4.10
2024-02-16 -4.92
2024-02-15 -5.54
2024-02-14 -5.13
2024-02-13 -4.53
2024-02-12 -4.52
2024-02-09 -3.70
2024-02-08 -3.56
2024-02-07 -3.32
2024-02-06 -3.42
2024-02-05 -3.17
2024-02-02 -3.29
2024-02-01 -3.06
2024-01-31 -2.89
2024-01-30 -2.72
2024-01-29 -2.97
2024-01-26 -2.81
2024-01-25 -2.75
2024-01-24 -2.68
2024-01-23 -2.47
2024-01-22 -2.13
2024-01-19 -2.01
2024-01-18 -2.01
2024-01-17 -2.12
2024-01-16 -2.04
2024-01-12 -2.12
2024-01-11 -2.18
2024-01-10 -2.24
2024-01-09 -2.29
2024-01-08 -2.37
2024-01-05 -2.28
2024-01-04 -2.47
2024-01-03 -2.34
2024-01-02 -2.46
2023-12-29 -2.37
2023-12-28 -2.37
2023-12-27 -2.26
2023-12-26 -2.18
2023-12-22 -2.03
2023-12-21 -1.96
2023-12-20 -1.89
2023-12-19 -1.96
2023-12-18 -1.87
2023-12-15 -1.96
2023-12-14 -2.01
2023-12-13 -1.98
2023-12-12 -1.82